The present study was designed to examine the effect of Pseudomonas aeruginosa alkaline protease (AP) and elastase (Ela) on human natural killer (NK) cell activity in vitro. AP and Ela were found to inhibit NK cell function. Addition of alpha interferon and interleukin-2 did not abolish this inhibition of NK cell activity. Adhesion of effector to target cells was studied in a single-cell agarose assay of monocyte-depleted NK-cellenriched cell populations. AP and Ela were shown to inhibit effector/target cell conjugate formation. Furthermore, AP and Ela inhibited the binding of the monoclonal antibody Leu-ll, which reacts with the Fc receptor of NK cells. The inhibition of NK cell binding to the target cell by P. aeruginosa proteases is most likely due to proteolytic cleavage of the surface receptors involved in the binding of the effector cell to the target cell.
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There is increasing evidence that natural killer (NK) cells play an important role in immune system surveillance against viral infections, whereas there is little available information on the interaction between bacteria and NK cells (5, 12, 13) . Pseudomonas aeruginosa is an opportunistic pathogen which has become an important clinical problem in immunocompromised hosts such as cystic fibrosis patients and burn patients (3, 6) . It has been suggested that alkaline protease (AP) and elastase (Ela), the extracellular products of P. aeruginosa, are involved in the pathogenesis (1, 7) of lung diseases associated with this bacterium. The role of these products in interfering with human neutrophil function is well established by our group and by others (8-10, 18, 21) . In the present study, the effect of AP and Ela on NK cell function, effector/target cell binding, and cell surface receptors is described.
MATERIALS AND METHODS
Effector cells. Mononuclear cells were isolated from heparinized blood (125 IU/ml of blood) by Ficoll-Isopaque gradient centrifugation. The cells were washed three times with Hanks balanced salt solution and suspended in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS) to a concentration of 4 x 106 cells per ml. In some experiments, 1.5 ml was incubated at 37°C on 60-mm plastic petri dishes (Teknunc A/S, Roskilde, Denmark) for 1 h. The nonadherent cells were aspirated, centrifuged (1,000 x g, 10 min), and resuspended in RPMI 1640 supplemented with 10% FCS to a final concentration of 4 x 106 cells per ml. This suspension contained 0 to 2% peroxidase-positive cells (22) .
In other experiments, NK cell-enriched suspensions were prepared on discontinuous Percoll (Pharmacia, Uppsala, Sweden) gradients as previously described (18) . After Percoll fractionation, large granular lymphocytes (LGLs) were identified in Giemsa-stained cytocentrifuge preparations as medium-to large-sized lymphocytes with slightly indented nuclei and azurophilic granules. The Percollfractionated cell suspension contained 70 to 80% LGLs.
Target cells. The human leukemia cell line K-562 was maintained in continuous culture in RPMI 1640 supplemented with 10% heat-inactivated FCS. A 0.1-mCi amount * Corresponding author.
of Na251CrO4 (New England Nuclear Corp., Boston, Mass.), with a specific activity of 350 to 600 mCi/mg, was added to 2 x 106 to 8 x 106 target cells in 1 ml. The cells were incubated with the isotope for 1 h at 37°C. The labeled cells were washed through a 4-ml cushion of heat-inactivated FCS. The cell pellet was suspended in RPMI 1640 supplemented with 10% heat-inactivated FCS to yield a final concentration of 5 x 104 cells per ml.
Cytotoxicity assay. NK cell activity was measured in triplicate (standard deviation = 0.1 to 3.0%) at an effector/target cell ratio of 80:1 as previously described (14) . A 400-,I amount of the labeled target cell suspension was mixed with 400 ,ul of effector cells and 200 RI of RPMI 1640 supplemented with 10% heat-inactivated FCS. In one set of experiments, the cytotoxicity assay was performed in the absence of FCS. After incubation for 3 h at 37°C, the tubes were centrifuged (1,000 x g, 10 min), 500 ,ul of each supernatant was transferred to new tubes, and the radioactivity was counted in a Packard scintillation gamma counter. The experimental release was calculated by the following formula: [(activity released in the supematant)/(total activity)] x 100%. The specific release (the NK cell activity) was the difference between experimental release in the presence of effector cells and experimental release when target cells were incubated with medium only. Data are given as percentages of controls (mean + standard deviation). Possible toxic effects of AP (50 ,ug/ml) and Ela (25 ,ug/ml) were tested by staining effector cells and target cells with trypan blue. Cell viability was more than 99% after 4 h of incubation with the proteases.
Interferon treatment of effector cells. A 0.1-ml amount of alpha interferon (IFN-oa), 105 IU/ml, was added to 0.9 ml of effector cells (4 x 106 cells per ml) (2). IFN-a was kindly provided by Robert Jordal, Blood Bank, Copenhagen County Hospital, Gentofte, Denmark. After 1 h of incubation at 37°C, the cells were washed three times with RPMI 1640 supplemented with 10% FCS and resuspended in the same medium in the appropriate effector cell concentration.
IL-2 treatment of effector cells. Purified interleukin 2 (IL-2)
was purchased from Boehringer GmbH, Mannheim, Federal Republic of Germany. IL-2 was prepared from culture supernatants of pooled human T lymphocytes stimulated with phytohemagglutinin and purified by ammonium sulfate fractionation and DEAE column chromatography (14) . IL- Cell surface marker analysis by flow cytometry. For cell surface marker analysis by flow cytometry, the phycoerythrin-conjugated monoclonal antibody Leu-llc (Becton Dickinson) was used. Blood mononuclear cells (106) were washed twice in phosphate-buffered saline containing 5% FCS and resuspended in 100 ,l of phosphate-buffered saline containing 5% FCS and 5 ,ul of the monoclonal antibody. After incubation on ice for 45 min, the cells were washed twice in balanced electrolyte solution and finally resuspended in this solution. Labeled cells were then analyzed by flow cytometry by using a fluorescence-activated cell sorter analyzer (Becton Dickinson). A total of 5,000 cells were counted.
Statistical analysis. The significance of the observed differences was estimated by the Wilcoxon test; P c 0.05 was considered significant. was stored in small aliquots at -20°C until use. IL-2 at a final concentration of 10% was preincubated with 4 x 106 effector cells per ml for 1 h at 37°C. IL-2 was present during the incubation with target cells as well. The IL-2 preparation used in our experiments contained 300 IU/ml, measured as previously described (14) .
AP and Ela. AP and Ela were purchased from Nagase Chemical Sangwo, Osaka, Japan. The purity of each was confirmed by the demonstration of single bands when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis by the method of Laemmli (11) . The (Fig. 1A and B) , whereas 1 h of preincubation resulted in only slight inhibition (Fig. 1C) . AP (50 ,ug/ml) and Ela (25 ,ug/ml) induced total inhibition. AP at a concentration as low as 0.5 ,ug/ml inhibited NK cell activity by 20%, whereas concentrations of Ela lower than 10 ,ug/ml had almost no effect (Fig. 1A and B) . To determine whether the inhibitory effect of AP and Ela was abolished by washing the cells, effector cells were preincubated with the proteases for either 4 h followed by wash (Fig. 1A ) or 1 h followed by 3 h of incubation in the NK cell assay (Fig. 1B) . There was no major difference in inhibition of NK cell activity under these two incubation conditions.
When the NK cell assay was performed without FCS, the NK cell activity was inhibited by lower concentrations of Ela, whereas there was no significantly different effect of AP when the NK cell assay was performed without FCS, except at the 10 ,ug/ml concentration ( (Table 2) . To determine whether the inhibition of cytolysis was due to interference with the recognition and adhesion step or due to blocking of the final killing event, the %TBC after incubation with AP (50 ,ug/ml) or Ela (25 ,ug/ml) was studied in a single-cell agarose assay. In order to obtain a high effector/target cell binding, Percoll-fractionated NK cellenriched effector cells were used. %TBC without protease treatment was 12.2 3.1%. After treatment with AP, %TBC was 6.7 ± 2.4%, and after treatment with Ela, %TBC was 4.4 ± 1.9% (mean ± standard deviation; n = 3). The proteases thus inhibited NK cell activity by inhibition of effector/target cell conjugate formation.
Mononuclear cells were preincubated with either AP (50 ,ug/ml) or Ela (25 ,ug/ml) for 3 h, followed by incubation with the monoclonal antibody Leu-11. The percentage of mononuclear cells binding Leu-11 was 10.3 ± 4.1%. When mononuclear cells were preincubated with AP, the percentage of cells binding Leu-11 was reduced to 2.3 ± 2.3% (n = 10; P < 0.01), and when incubated with Ela the binding of Leu-11 was reduced to 1.4 ± 0.8% (n = 10; P < 0.01). DISCUSSION We have previously shown that P. aeruginosa proteases are capable of inhibiting human polymorphonuclear leukocyte chemotaxis and of interfering with oxidative metabolism and phagocytosis of these cells (8) (9) (10) . AP at a concentration as low as 0.05 ,ug/ml inhibited chemotaxis by 10%, and Ela at 0.0025 pug/ml inhibited chemotaxis by 25%. Higher concentrations of AP and Ela were necessary in order to inhibit NK cell cytotoxicity. However, complete inhibition of chemotaxis, as well as of NK cytotoxicity, was observed with 50 ,ug of AP and 25 ,ug of Ela per ml. The neutrophil studies indicated that the proteases act on the cell surface by proteolytic cleavage of the receptors involved in the cell functions examined. The present studies extend our previous observations and indicate a similar mechanism of action by P. aeruginosa proteases in using another cell type of the immune system, namely, the NK cell.
The data demonstrate that these proteases inhibit the cytotoxic activity of the NK cells against a tumor target cell. The finding that the inhibitory effect was not abrogated after removal of the proteases from effector cells by washing demonstrates that the proteases act selectively on the effector cell itself.
Heat inactivation of the enzymes under conditions which destroy the enzymatic effect but which do not destroy completely the protein structure abolished the inhibitory effect of AP and Ela. The inhibitory activity of the proteases was thus due to the enzymatic activity of the proteases and not due to a nonspecific binding of the protein. That lower concentrations of the proteases inhibited NK cell activity when the experiments were performed in the absence of FCS is in accordance with the fact that FCS contains protein substrates for both enzymes. IFN-(x and IL-2 did not abolish the protease-induced inhibition of NK cell cytotoxicity. This is understandable, since IFN-a increases NK cell activity by enhancement of the adhesion of effector to target cells and by increasing the ability of LGLs to recycle from target to target during the killing process (17, 19, 20) . This adhesion step was blocked by Pseudomonas exoproteases. IL-2 may enhance NK cell activity by inducing gamma interferon in activated lymphocytes and may thereby increase effector/target cell adhesion (21) .
We have recently shown that immune complexes inhibit NK cell cytotoxicity by interfering with the adhesion of effector cells to target cells (15) . The inhibition seems to occur via steric hindrance of specific NK cell receptors that recognize target structures and that are physically close to Fc receptors. The NK cell receptor has not been identified, and monoclonal antibodies against this receptor are not available. It is known that the monoclonal antibody reacts with the Fc receptor of NK cells (CD16) (16) . The findings on the inhibition of binding of anti-Leu-11 monoclonal antibodies to NK cells by P. aeruginosa exoproteases provide further support for the mechanism of action of these proteases by proteolytic cleavage of receptors.
Taken together, these findings indicate that P. aeruginosa exoproteases act on the cell surface of NK cells, most probably by proteolytic cleavage of the receptors involved in effector/target cell binding, and on NK cell cytotoxicity.
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